Literature DB >> 19644496

Genetic correction of hematopoiesis in Fanconi anemia: the case for a non-HSC-autonomous defect.

Amy M Skinner1, Peter Kurre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19644496      PMCID： PMC2835248          DOI： 10.1038/mt.2009.138

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  20 in total

Review 1.  Regulation of hematopoiesis and its interaction with stem cell niches.

Authors:  Fumio Arai; Atsushi Hirao; Toshio Suda
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

2.  Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells.

Authors:  P Kurre; P Anandakumar; H-P Kiem
Journal:  Gene Ther       Date:  2006-02       Impact factor: 5.250

3.  Phenotypic correction of Fanconi anemia group C knockout mice.

Authors:  K A Gush; K L Fu; M Grompe; C E Walsh
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

Review 4.  Fanconi anemia.

Authors:  Grover C Bagby; Blanche P Alter
Journal:  Semin Hematol       Date:  2006-07       Impact factor: 3.851

5.  Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).

Authors:  J M Liu; S Kim; E J Read; M Futaki; I Dokal; C S Carter; S F Leitman; M Pensiero; N S Young; C E Walsh
Journal:  Hum Gene Ther       Date:  1999-09-20       Impact factor: 5.695

6.  Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy.

Authors:  Xiaxin Li; Michelle M Le Beau; Samantha Ciccone; Feng-Chun Yang; Brian Freie; Shi Chen; Jin Yuan; Ping Hong; Attilio Orazi; Laura S Haneline; D Wade Clapp
Journal:  Blood       Date:  2005-01-11       Impact factor: 22.113

7.  Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.

Authors:  Ariana Jacome; Susana Navarro; Paula Río; Rosa M Yañez; Africa González-Murillo; M Luz Lozano; Maria Luisa Lamana; Julian Sevilla; Teresa Olive; Cristina Diaz-Heredia; Isabel Badell; Jesus Estella; Luis Madero; Guillermo Guenechea; José Casado; Jose C Segovia; Juan A Bueren
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

8.  Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control.

Authors:  Xiaxin Li; P Artur Plett; Yanzhu Yang; Ping Hong; Brian Freie; Edward F Srour; Christie M Orschell; D Wade Clapp; Laura S Haneline
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

9.  Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.

Authors:  Francesco Galimi; Meenakshi Noll; Yoshiyuki Kanazawa; Timothy Lax; Cindy Chen; Markus Grompe; Inder M Verma
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

10.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.

Authors:  Hal E Broxmeyer; Christie M Orschell; D Wade Clapp; Giao Hangoc; Scott Cooper; P Artur Plett; W Conrad Liles; Xiaxin Li; Barbara Graham-Evans; Timothy B Campbell; Gary Calandra; Gary Bridger; David C Dale; Edward F Srour
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.